Skip to main content
icon for Ebola case in the US by June 30?

Ebola case in the US by June 30?

icon for Ebola case in the US by June 30?

Ebola case in the US by June 30?

11% chance
Polymarket
NOVO
11% chance
Polymarket
NOVO
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the United States of America reported between market creation and June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". Any active laboratory-confirmed Ebola infection identified within U.S. territory will qualify, regardless of where exposure, symptom onset, or testing occurred. The primary resolution source for this market will be official government information (e.g., the CDC); however, an overwhelming consensus of credible reporting will also suffice.The strong market-implied odds against an Ebola case reaching the United States by June 30 reflect the current outbreak's confinement to remote health zones in Ituri Province, Democratic Republic of the Congo, where Africa CDC reports 246 suspected cases and 65 deaths as of May 15, 2026, with laboratory confirmation of a Bundibugyo strain in only a small subset. This localized transmission, compounded by ongoing security constraints and limited population mobility to major international airports, aligns with CDC assessments of extremely low importation risk, bolstered by established U.S. entry screening protocols and the absence of any confirmed or travel-linked cases outside the region. Historical patterns of prior Ebola outbreaks show rare long-distance exportation when rapid containment measures are deployed, and the short remaining timeframe through June further reinforces trader consensus favoring no U.S. detection.

This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the United States of America reported between market creation and June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

Any active laboratory-confirmed Ebola infection identified within U.S. territory will qualify, regardless of where exposure, symptom onset, or testing occurred.

The primary resolution source for this market will be official government information (e.g., the CDC); however, an overwhelming consensus of credible reporting will also suffice.
Volume
$866
Data de Término
30 jun 2026
Mercado Aberto
May 15, 2026, 3:04 PM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the United States of America reported between market creation and June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". Any active laboratory-confirmed Ebola infection identified within U.S. territory will qualify, regardless of where exposure, symptom onset, or testing occurred. The primary resolution source for this market will be official government information (e.g., the CDC); however, an overwhelming consensus of credible reporting will also suffice.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the United States of America reported between market creation and June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". Any active laboratory-confirmed Ebola infection identified within U.S. territory will qualify, regardless of where exposure, symptom onset, or testing occurred. The primary resolution source for this market will be official government information (e.g., the CDC); however, an overwhelming consensus of credible reporting will also suffice.The strong market-implied odds against an Ebola case reaching the United States by June 30 reflect the current outbreak's confinement to remote health zones in Ituri Province, Democratic Republic of the Congo, where Africa CDC reports 246 suspected cases and 65 deaths as of May 15, 2026, with laboratory confirmation of a Bundibugyo strain in only a small subset. This localized transmission, compounded by ongoing security constraints and limited population mobility to major international airports, aligns with CDC assessments of extremely low importation risk, bolstered by established U.S. entry screening protocols and the absence of any confirmed or travel-linked cases outside the region. Historical patterns of prior Ebola outbreaks show rare long-distance exportation when rapid containment measures are deployed, and the short remaining timeframe through June further reinforces trader consensus favoring no U.S. detection.

This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the United States of America reported between market creation and June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

Any active laboratory-confirmed Ebola infection identified within U.S. territory will qualify, regardless of where exposure, symptom onset, or testing occurred.

The primary resolution source for this market will be official government information (e.g., the CDC); however, an overwhelming consensus of credible reporting will also suffice.
Volume
$866
Data de Término
30 jun 2026
Mercado Aberto
May 15, 2026, 3:04 PM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the United States of America reported between market creation and June 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". Any active laboratory-confirmed Ebola infection identified within U.S. territory will qualify, regardless of where exposure, symptom onset, or testing occurred. The primary resolution source for this market will be official government information (e.g., the CDC); however, an overwhelming consensus of credible reporting will also suffice.

Cuidado com os links externos.

Frequently Asked Questions

"Ebola case in the US by June 30?" is a prediction market on Polymarket where traders buy and sell "Yes" or "No" shares based on whether they believe this event will happen. The current crowd-sourced probability is 11% for "Yes." For example, if "Yes" is priced at 11¢, the market collectively assigns a 11% chance that this event will occur. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

"Ebola case in the US by June 30?" is a newly created market on Polymarket, launched on May 15, 2026. As an early market, this is your opportunity to be among the first traders to set the odds and establish the market's initial price signals. You can also bookmark this page to track volume and trading activity as the market gains traction over time.

To trade on "Ebola case in the US by June 30?," simply choose whether you believe the answer is "Yes" or "No." Each side has a current price that reflects the market's implied probability. Enter your amount and click "Trade." If you buy "Yes" shares and the outcome resolves as "Yes," each share pays out $1. If it resolves as "No," your "Yes" shares pay $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

The current probability for "Ebola case in the US by June 30?" is 11% for "Yes." This means the Polymarket crowd currently believes there is a 11% chance that this event will occur. These odds update in real-time based on actual trades, providing a continuously updated signal of what the market expects to happen.

The resolution rules for "Ebola case in the US by June 30?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.